Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner about NIH’s terminology transition and related updates is no longer displayed above the 403 error page.
    Difference
    1%
    Check dated 2026-11-07T14:54:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0, while the study page remains an access-denied error.
    Difference
    0.2%
    Check dated 2026-10-31T15:33:51.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition and links to updates and FAQs, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T17:32:49.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-17T17:09:26.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T18:10:33.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and a minimal header, replacing the previously visible study details, locations, and associated documents.
    Difference
    18%
    Check dated 2026-09-19T21:53:06.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.